IPVS Board Elections 2018 Results
We are pleased to announce the results of the recent IPVS Board Elections anticipating the IPVS General Assembly to take place in Sydney on October 5th 2018 in the margin of the IPVC 2018, where all elected candidates will take office.
P. J. F Snijders – goodbye to our dear colleague
His warm smile, friendly disposition and positive attitude will be remembered and missed by all who knew him and we want to acknowledge Peter’s talents as a scientist and contributions to the field. Peter was a fine human being and we are all proud that we were able to be called his colleague.
Some news about the Papillomavirus Research (PVR) Journal
PVR is now listed in Medline and the Pubmed Central indexing system. IPVS members benefit from free OA fees for 2018.
WHO is calling for global action to end cervical cancer
WHO Director-General, Dr Tedros Adhanom Ghebreyesus made a global call for action on 19th May 2018 towards the elimination of cervical cancer.
IPVS proudly sponsors the Marjorie Bash Foundation project: « We Can, I Can Conquer Cervical Cancer ».
The project had as objectives to teach over 2,000 high school students in Abia State and other parts of Nigeria about cervical cancer and how they might prevent the disease or detect it early.
Unitaid launches call for proposals to help eliminate cervical cancer
Geneva – Unitaid is seeking to fund smart, innovative projects that will help eliminate cervical cancer, a leading cause of death in low- and middle-income countries, particularly among women with HIV.
Surviving Cancer: Jason wants to tell you his story…
At 44 years of age, Jason was diagnosed with Stage IV HPV Throat Cancer. With a wife and three children, he was determined to survive. Now he wants to stop anyone else from having to go through what he did.
4th Latin American Human Papillomavirus Symposium April 26 – 27, 2018- Buenos Aires, Argentina
IPVS was delighted to support and endorse the 4th Latin American Human Papillomavirus Symposium on April 26-27 in Buenos Aires Argentina.
The critical role of stakeholder collaborations: Aiming for the elimination of HPV-related disease in Europe
Despite the availability of a vaccine proven to be an effective primary prevention measure to reduce the burden of HPV-related cancers, many challenges remain to achieve universal, gender-neutral HPV vaccination in the EU. Such challenges were discussed at a roundtable of EU and national experts and patients in Brussels in December 2017.
Scam Alert: do not accept invitations from this publisher
Please make sure that you do not accept invitations nor submit research to this publisher